• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白:关于其结构、生理功能、调节及疾病中的改变的新见解

P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.

作者信息

Ahmed Juvale Iman Imtiyaz, Abdul Hamid Azzmer Azzar, Abd Halim Khairul Bariyyah, Che Has Ahmad Tarmizi

机构信息

Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian, Kota Bharu, 16150, Kelantan, Malaysia.

Department of Biotechnology, Kulliyyah of Science, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, 25200, Kuantan, Pahang, Malaysia.

出版信息

Heliyon. 2022 Jun 22;8(6):e09777. doi: 10.1016/j.heliyon.2022.e09777. eCollection 2022 Jun.

DOI:10.1016/j.heliyon.2022.e09777
PMID:35789865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9249865/
Abstract

The multidrug resistance phenomenon presents a major threat to the pharmaceutical industry. This resistance is a common occurrence in several diseases and is mediated by multidrug transporters that actively pump substances out of the cell and away from their target regions. The most well-known multidrug transporter is the P-glycoprotein transporter. The binding sites within P-glycoprotein can accommodate a variety of compounds with diverse structures. Hence, numerous drugs are P-glycoprotein substrates, with new ones being identified every day. For many years, the mechanisms of action of P-glycoprotein have been shrouded in mystery, and scientists have only recently been able to elucidate certain structural and functional aspects of this protein. Although P-glycoprotein is highly implicated in multidrug resistant diseases, this transporter also performs various physiological roles in the human body and is expressed in several tissues, including the brain, kidneys, liver, gastrointestinal tract, testis, and placenta. The expression levels of P-glycoprotein are regulated by different enzymes, inflammatory mediators and transcription factors; alterations in which can result in the generation of a disease phenotype. This review details the discovery, the recently proposed structure and the regulatory functions of P-glycoprotein, as well as the crucial role it plays in health and disease.

摘要

多药耐药现象对制药行业构成了重大威胁。这种耐药性在多种疾病中普遍存在,由多药转运蛋白介导,这些转运蛋白能主动将物质泵出细胞,使其远离靶区域。最著名的多药转运蛋白是P - 糖蛋白转运体。P - 糖蛋白内的结合位点可以容纳各种结构各异的化合物。因此,众多药物都是P - 糖蛋白的底物,而且每天都有新的底物被发现。多年来,P - 糖蛋白的作用机制一直笼罩在神秘之中,科学家直到最近才能够阐明该蛋白的某些结构和功能方面。尽管P - 糖蛋白与多药耐药性疾病密切相关,但这种转运蛋白在人体中也发挥着各种生理作用,并且在包括大脑、肾脏、肝脏、胃肠道、睾丸和胎盘在内的多个组织中表达。P - 糖蛋白的表达水平受不同的酶、炎症介质和转录因子调节;这些因素的改变可能导致疾病表型的产生。本综述详细介绍了P - 糖蛋白的发现、最近提出的结构和调节功能,以及它在健康和疾病中所起的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/ad4a3e77cff1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/68e4d62a1158/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/0d954e7a4ea5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/ad4a3e77cff1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/68e4d62a1158/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/0d954e7a4ea5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8028/9249865/ad4a3e77cff1/gr3.jpg

相似文献

1
P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.P-糖蛋白:关于其结构、生理功能、调节及疾病中的改变的新见解
Heliyon. 2022 Jun 22;8(6):e09777. doi: 10.1016/j.heliyon.2022.e09777. eCollection 2022 Jun.
2
Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.锝(III)膦配合物作为多药耐药性P-糖蛋白的转运底物及血脑屏障处P-糖蛋白功能标志物的表征
Biochemistry. 1997 Nov 18;36(46):14218-27. doi: 10.1021/bi971931z.
3
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.多药耐药蛋白:P-糖蛋白、多药耐药相关蛋白1、多药耐药相关蛋白2和乳腺癌耐药蛋白(ABCG2)在组织防御中的作用
Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37. doi: 10.1016/j.taap.2004.10.012.
4
P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.P-糖蛋白——肿瘤细胞代谢及癌症治疗的意义
Curr Cancer Drug Targets. 2005 Sep;5(6):457-68. doi: 10.2174/1568009054863636.
5
ATP-binding cassette transporters in reproduction: a new frontier.生殖中的ATP结合盒转运蛋白:一个新领域。
Hum Reprod Update. 2016 Mar-Apr;22(2):164-81. doi: 10.1093/humupd/dmv049. Epub 2015 Nov 5.
6
A primer on the mechanics of P-glycoprotein the multidrug transporter.多药转运蛋白P-糖蛋白的作用机制入门
Pharmacol Res. 2007 Jan;55(1):1-15. doi: 10.1016/j.phrs.2006.10.007. Epub 2006 Oct 20.
7
New insight into p-glycoprotein as a drug target.对 P-糖蛋白作为药物靶点的新认识。
Anticancer Agents Med Chem. 2013 Jan;13(1):159-70.
8
Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.乳腺癌耐药蛋白、多药耐药相关蛋白 2 和 P-糖蛋白活性调节剂的结合部位相互作用。
Mol Pharm. 2020 Jul 6;17(7):2398-2410. doi: 10.1021/acs.molpharmaceut.0c00155. Epub 2020 Jun 18.
9
Molecular analysis of the multidrug transporter.多药转运蛋白的分子分析
Cytotechnology. 1993;12(1-3):33-62. doi: 10.1007/BF00744657.
10
Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.多药耐药相关蛋白:一种与参与细胞毒性药物外排的P-糖蛋白不同的蛋白质。
Gen Pharmacol. 1997 May;28(5):639-45. doi: 10.1016/s0306-3623(96)00284-4.

引用本文的文献

1
A multimodal contrastive learning framework for predicting P-glycoprotein substrates and inhibitors.一种用于预测P-糖蛋白底物和抑制剂的多模态对比学习框架。
J Pharm Anal. 2025 Aug;15(8):101313. doi: 10.1016/j.jpha.2025.101313. Epub 2025 Apr 16.
2
Advanced strategies to overcome multidrug resistance in cancer therapy: progress in P-glycoprotein inhibitors, drug delivery, and personalized medicine.癌症治疗中克服多药耐药性的先进策略:P-糖蛋白抑制剂、药物递送及个性化医疗的进展
Invest New Drugs. 2025 Sep 2. doi: 10.1007/s10637-025-01562-3.
3
Recent Advances in Microtubule Targeting Agents for Cancer Therapy.

本文引用的文献

1
Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics.美国食品药品监督管理局(FDA)批准的具有P-糖蛋白抑制活性的药物用于潜在癌症治疗的临床前景
Front Oncol. 2020 Nov 16;10:561936. doi: 10.3389/fonc.2020.561936. eCollection 2020.
2
Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes.MDR1 转运蛋白在细胞毒性 T 淋巴细胞中的生理表达和功能。
J Exp Med. 2020 May 4;217(5). doi: 10.1084/jem.20191388.
3
Perplexing Role of P-Glycoprotein in Tumor Microenvironment.
用于癌症治疗的微管靶向剂的最新进展
Molecules. 2025 Aug 8;30(16):3314. doi: 10.3390/molecules30163314.
4
Elucidating the Complex Structural and Molecular Mechanisms Driving P-Glycoprotein-Mediated Transport of Cardiac Glycosides.阐明驱动P-糖蛋白介导的强心苷转运的复杂结构和分子机制。
Int J Mol Sci. 2025 Aug 13;26(16):7813. doi: 10.3390/ijms26167813.
5
β-Lactam Potentiating Activity, Molecular Docking, and ADMET Analysis of 3-Substituted Coumarins.3-取代香豆素的β-内酰胺增强活性、分子对接及ADMET分析
Curr Microbiol. 2025 Jul 30;82(9):422. doi: 10.1007/s00284-025-04397-6.
6
Piperidine and valproic acid hybrid compound (F2S4--VPA) outperforms methotrexate as anti-proliferative and cells migration inhibition.哌啶与丙戊酸杂化化合物(F2S4--VPA)在抗增殖和抑制细胞迁移方面比甲氨蝶呤表现更优。
RSC Adv. 2025 Jul 16;15(31):25291-25309. doi: 10.1039/d5ra01365h. eCollection 2025 Jul 15.
7
P-glycoprotein expression skews mitochondrial dye measurements in T cells.P-糖蛋白表达使T细胞中线粒体染料测量结果出现偏差。
Front Immunol. 2025 Jun 18;16:1560104. doi: 10.3389/fimmu.2025.1560104. eCollection 2025.
8
A Systematic Review of ABCB1 Polymorphisms and Antiseizure Medication Resistance: Insights from Effect Size and Study Power Analysis.ABCB1基因多态性与抗癫痫药物耐药性的系统评价:效应量和研究效能分析的见解
Int J Mol Sci. 2025 Jun 10;26(12):5548. doi: 10.3390/ijms26125548.
9
Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson's disease: a high-throughput investigation through molecular docking and dynamic simulation.千金藤素和番茄碱作为新型LpxC和TLR4抑制剂减轻帕金森病肠道介导炎症的潜力:通过分子对接和动态模拟的高通量研究
3 Biotech. 2025 Jul;15(7):215. doi: 10.1007/s13205-025-04386-3. Epub 2025 Jun 16.
10
Case Report: Adverse reaction to butorphanol in a Collie homozygous for the () mutation.病例报告:一只对()突变纯合的柯利犬对布托啡诺的不良反应。
Front Vet Sci. 2025 May 29;12:1603375. doi: 10.3389/fvets.2025.1603375. eCollection 2025.
P-糖蛋白在肿瘤微环境中的复杂作用
Front Oncol. 2020 Mar 5;10:265. doi: 10.3389/fonc.2020.00265. eCollection 2020.
4
Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy.癫痫患者丙戊酸治疗后外周 PTGS2/COX-2 下调。
Sci Rep. 2020 Feb 13;10(1):2546. doi: 10.1038/s41598-020-59259-x.
5
Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients.肌萎缩侧索硬化症患者中 P-糖蛋白和乳腺癌耐药蛋白的表达及细胞分布。
J Neuropathol Exp Neurol. 2020 Mar 1;79(3):266-276. doi: 10.1093/jnen/nlz142.
6
Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer.黄酮卡瓦因A在抑制肺癌紫杉醇耐药中P-糖蛋白表达的活性及机制
Oncol Lett. 2020 Jan;19(1):379-387. doi: 10.3892/ol.2019.11069. Epub 2019 Nov 8.
7
Modulation of Wnt/β-catenin signaling promotes blood-brain barrier phenotype in cultured brain endothelial cells.Wnt/β-catenin 信号通路的调控促进体外脑内皮细胞血脑屏障表型的形成。
Sci Rep. 2019 Dec 23;9(1):19718. doi: 10.1038/s41598-019-56075-w.
8
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis.功能获得性 p53 突变:条条大路通肿瘤发生。
Int J Mol Sci. 2019 Dec 8;20(24):6197. doi: 10.3390/ijms20246197.
9
The role of P-glycoprotein (P-gp) and inwardly rectifying potassium (Kir) channels in sudden unexpected death in epilepsy (SUDEP).P-糖蛋白(P-gp)和内向整流钾(Kir)通道在癫痫猝死(SUDEP)中的作用。
Epilepsy Behav. 2021 Aug;121(Pt B):106590. doi: 10.1016/j.yebeh.2019.106590. Epub 2019 Nov 6.
10
Estradiol regulation of P-glycoprotein expression in mouse kidney and human tubular epithelial cells, implication for renal clearance of drugs.雌二醇对小鼠肾脏和人肾小管上皮细胞 P-糖蛋白表达的调节及其对药物肾清除率的影响。
Biochem Biophys Res Commun. 2019 Nov 12;519(3):613-619. doi: 10.1016/j.bbrc.2019.09.021. Epub 2019 Sep 17.